Pharming Group (PHAR) reported $376M in revenue for fiscal 2025, +26.6% year on year. That ranks #2382 by revenue among 2853 SEC filers and #235 in Healthcare. Net income was $2.9M, a net margin of 0.8%. Revenue has grown 12.1% a year on average since 2019 ($189M then). The fiscal 2025 balance sheet shows $500M in total assets and $145M in cash.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractsWithCustomers | $376M | +26.6% | FY20252025-12-31 |
| Gross profitGrossProfit | $331M | +26.3% | FY20252025-12-31 |
| Operating incomeProfitLossFromOperatingActivities | $25.8M | +$34.5M | FY20252025-12-31 |
| Net incomeProfitLossAttributableToOwnersOfParent | $2.9M | +$14.7M | FY20252025-12-31 |
| Operating cash flowCashFlowsFromUsedInOperatingActivities | $54.7M | +$56.5M | FY20252025-12-31 |
| Capital expenditurePurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | $749,000 | −5.2% | FY20252025-12-31 |
| Total assetsAssets | $500M | +25.0% | FY20252025-12-31 |
| Shareholders' equityEquity | $277M | +25.4% | FY20252025-12-31 |
| CashCashAndCashEquivalents | $145M | +164.5% | FY20252025-12-31 |
| Long-term debt | Not reported | — |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Figures are reported under IFRS, in US dollars.
Profile
- Legal name
- Pharming Group N.V.
- Ticker
- PHAR
- Exchange
- Nasdaq
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 12-31
- CIK
- 0001828316
Filings
- 20-FApr 2, 2026Open filing →
- 20-FApr 3, 2025Open filing →
- 20-FApr 4, 2024Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Sonida Senior LivingSNDA | $381M | −$72.5M |
| CaredxCDNA | $380M | −$21.4M |
| Twist BioscienceTWST | $377M | −$77.7M |
| Pharming GroupPHAR | $376M | $2.9M |
| Arcutis BiotherapeuticsARQT | $376M | −$16.1M |
| InmodeINMD | $370M | $93.8M |
| MannkindMNKD | $349M | $5.9M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pharming Group — Key figures |url=https://companiesranked.com/en/company/pharming-group |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pharming Group — Key figures. CompaniesRanked. https://companiesranked.com/en/company/pharming-groupBibTeX
@misc{companiesranked-en-company-pharming-group-2026,
author = {{CompaniesRanked}},
title = {{Pharming Group — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pharming-group}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001828316-26-000015 · April 2, 2026
{{cite web |title=Pharming Group — Key figures — 20-F (0001828316-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1828316/000182831626000015/pharm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-04-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.